Open Access
Open access
Elsevier
The Lancet
,  volume 405 ,  issue 10480 ,  pages 751-754

Assessing the oncogenic risk: the long-term safety of autologous chimeric antigen receptor T cells

Publication type: Journal Article
Publication date: 2025-03-01
Elsevier
scimago Q1
wos Q1
SJR: 12.113
CiteScore: 87.6
Impact factor: 88.5
ISSN: 01406736, 1474547X
Found 
Found 

Top-30

Journals

1
The CRISPR Journal
The CRISPR Journal, 1, 12.5%
The CRISPR Journal
1 publication, 12.5%
Scientific Reports
Scientific Reports, 1, 12.5%
Scientific Reports
1 publication, 12.5%
Molecular Therapy
Molecular Therapy, 1, 12.5%
Molecular Therapy
1 publication, 12.5%
Transfusionsmedizin
Transfusionsmedizin, 1, 12.5%
Transfusionsmedizin
1 publication, 12.5%
Frontiers in Immunology
Frontiers in Immunology, 1, 12.5%
Frontiers in Immunology
1 publication, 12.5%
Cells
Cells, 1, 12.5%
Cells
1 publication, 12.5%
Blood Reviews
Blood Reviews, 1, 12.5%
Blood Reviews
1 publication, 12.5%
Seminars in Immunology
Seminars in Immunology, 1, 12.5%
Seminars in Immunology
1 publication, 12.5%
1

Publishers

1
2
3
Elsevier
Elsevier, 3, 37.5%
Elsevier
3 publications, 37.5%
Mary Ann Liebert
Mary Ann Liebert, 1, 12.5%
Mary Ann Liebert
1 publication, 12.5%
Springer Nature
Springer Nature, 1, 12.5%
Springer Nature
1 publication, 12.5%
Georg Thieme Verlag KG
Georg Thieme Verlag KG, 1, 12.5%
Georg Thieme Verlag KG
1 publication, 12.5%
Frontiers Media S.A.
Frontiers Media S.A., 1, 12.5%
Frontiers Media S.A.
1 publication, 12.5%
MDPI
MDPI, 1, 12.5%
MDPI
1 publication, 12.5%
1
2
3
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
8
Share
Cite this
GOST |
Cite this
GOST Copy
Baker D. J. et al. Assessing the oncogenic risk: the long-term safety of autologous chimeric antigen receptor T cells // The Lancet. 2025. Vol. 405. No. 10480. pp. 751-754.
GOST all authors (up to 50) Copy
Baker D. J., Levine B. L., June C. H. Assessing the oncogenic risk: the long-term safety of autologous chimeric antigen receptor T cells // The Lancet. 2025. Vol. 405. No. 10480. pp. 751-754.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/s0140-6736(25)00039-x
UR - https://linkinghub.elsevier.com/retrieve/pii/S014067362500039X
TI - Assessing the oncogenic risk: the long-term safety of autologous chimeric antigen receptor T cells
T2 - The Lancet
AU - Baker, Daniel J.
AU - Levine, Bruce L.
AU - June, Carl H.
PY - 2025
DA - 2025/03/01
PB - Elsevier
SP - 751-754
IS - 10480
VL - 405
SN - 0140-6736
SN - 1474-547X
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2025_Baker,
author = {Daniel J. Baker and Bruce L. Levine and Carl H. June},
title = {Assessing the oncogenic risk: the long-term safety of autologous chimeric antigen receptor T cells},
journal = {The Lancet},
year = {2025},
volume = {405},
publisher = {Elsevier},
month = {mar},
url = {https://linkinghub.elsevier.com/retrieve/pii/S014067362500039X},
number = {10480},
pages = {751--754},
doi = {10.1016/s0140-6736(25)00039-x}
}
MLA
Cite this
MLA Copy
Baker, Daniel J., et al. “Assessing the oncogenic risk: the long-term safety of autologous chimeric antigen receptor T cells.” The Lancet, vol. 405, no. 10480, Mar. 2025, pp. 751-754. https://linkinghub.elsevier.com/retrieve/pii/S014067362500039X.